Have a symptom?
See what questions
a doctor would ask.
News » Different hypertension drug therapy combinations pose different level of risk

Different hypertension drug therapy combinations pose different level of risk

There are three classes of blood pressure drugs: ACE inhibitors, calcium channel blockers and beta blockers. These drugs are frequently used in combination with a diuretic to control high blood pressure. A study published in the Journal of the American Medical Association reports that the rate of fatal heart attacks was doubled in women who used calcium channel blockers and diuretics compared to those on other therapies. The risk of cardiovascular death was 85% greater in women taking the calcium channel blocker and diuretic combination compared to those taking a beta blocker and diuretic. Nevertheless, the total risk of cardiovascular death from use of the combination therapy is actually quite small. The study involved 30,000 post menopausal women with high blood pressure but no heart disease.

Source: summary of medical news story as reported by The WMUR Channel

Related Disease Topics:

Article Source Details

About: Different hypertension drug therapy combinations pose different level of risk

Date: 15 December 2004

Source: The WMUR Channel


Related Medical Topics

This summary article refers to the following medical categories:

More News Topics

  • AIDS still leaving orphans
  • AIDS vaccine effective in small trials
  • Air in churches exposes churchgoers to risk of lung cancer
  • Air pollution linked to cardiovascular disease
  • Alcohol and smoking a strong risk factors for mouth cancer
  • Alcohol and substance abuse in elderly often diagnosed as dementia
  • Alcohol consumption amplifies allergy reaction
  • Alcohol consumption associated with heart arrhythmia
  • Alcohol consumption may have a protective effect against metabolic syndrome
  • Alcohol consumption without food increases risk of hypertension
  • Alcohol promotes growth of blood vessels supplying tumor
  • Alert caregiving for Alzheimer's patients
  • Alimta approved for use against certain cancers in the European Union
  • All about irritable bowel syndrome
  • All about obesity

    By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.

    Home | Symptoms | Diseases | Diagnosis | Videos | Tools | Forum | About Us | Terms of Use | Privacy Policy | Site Map | Advertise